The article you just read was brought to you by a few thousand dedicated readers. Will you join them?

Thanks for coming by The Tyee and reading one of many original articles we’ll post today. Our team works hard to publish in-depth stories on topics that matter on a daily basis. Our motto is: No junk. Just good journalism.

Just as we care about the quality of our reporting, we care about making our stories accessible to all who want to read them and provide a pleasant reading experience. No intrusive ads to distract you. No paywall locking you out of an article you want to read. No clickbait to trick you into reading a sensational article.

There’s a reason why our site is unique and why we don’t have to rely on those tactics — our Tyee Builders program. Tyee Builders are readers who chip in a bit of money each month (or one-time) to our editorial budget. This amazing program allows us to pay our writers fairly, keep our focus on quality over quantity of articles, and provide a pleasant reading experience for those who visit our site.

In the past year, we’ve been able to double our staff team and boost our reporting. We invest all of the revenue we receive into producing more and better journalism. We want to keep growing, but we need your support to do it.

Fewer than 1 in 100 of our average monthly readers are signed up to Tyee Builders. If we reach 1% of our readers signing up to be Tyee Builders, we could continue to grow and do even more.

If you appreciate what The Tyee publishes and want to help us do more, please sign up to be a Tyee Builder today. You pick the amount, and you can cancel any time.

Support our growing independent newsroom and join Tyee Builders today.
Before you click away, we have something to ask you…

Do you value independent journalism that focuses on the issues that matter? Do you think Canada needs more in-depth, fact-based reporting? So do we. If you’d like to be part of the solution, we’d love it if you joined us in working on it.

The Tyee is an independent, paywall-free, reader-funded publication. While many other newsrooms are getting smaller or shutting down altogether, we’re bucking the trend and growing, while still keeping our articles free and open for everyone to read.

The reason why we’re able to grow and do more, and focus on quality reporting, is because our readers support us in doing that. Over 5,000 Tyee readers chip in to fund our newsroom on a monthly basis, and that supports our rockstar team of dedicated journalists.

Join a community of people who are helping to build a better journalism ecosystem. You pick the amount you’d like to contribute on a monthly basis, and you can cancel any time.

Help us make Canadian media better by joining Tyee Builders today.
We value: Our readers.
Our independence. Our region.
The power of real journalism.
Get our free newsletter
Sign Up
News
  |  
Health
  |  
Coronavirus

The Search for a COVID-19 Treatment: A Tyee Video

QUICK WATCH: How Canadian researchers are progressing towards clinical trials for possible medicines that increase survival.

Tyee Staff 22 Apr 2020 | TheTyee.ca

U.S. President Donald Trump has been touting the unproven benefits of hydroxychloroquine, a malaria drug, as a possible treatment for COVID-19.

But moving from “hey, this might work” to prescribing a drug to sick people is complicated.

This short Tyee video — barely five minutes — explains what needs to happen, how clinical trials work and how we could be doing a better job and possibly getting treatments to patients faster.

Dr. Srinivas Murthy, an associate professor in the University of British Columbia department of pediatrics and an infectious disease specialist at BC Children’s Hospital, is working on clinical trials to test the effectiveness of three existing drugs in treating COVID-19 patients.

“The whole point of clinical trials is to figure out what works for patients and what doesn’t work,” he says. “Proving what doesn’t work is almost as important as proving what does work.”

Patients are randomly selected to get one of the three drugs or be treated with current best practices.

If the drugs don’t make a difference in outcomes, they’re dropped. If they do, they can be incorporated into treatment regimens.

But don’t expect magic cures. Trials may show only a small difference in outcomes.

That still matters, Murthy says. “A two-per-cent difference scaled out across this entire outbreak could be tens of thousands of lives.”

The efforts in Canada are part of the World Health Organization’s Solidarity Trial — an effort to link the work of 90 countries to identify possible treatments.

But Murthy says Canada’s contribution is lagging. The federal government has only provided funding to allow 20 hospitals to participate in the trials; another 80 want to take part in helping find a treatment.

“Canada, compared to other countries, is well behind.”

This video is the second in a series of pandemic-related videos in partnership with Vancouver’s Avo Media team of Jesse Lupini, Koby Michaels and Lucas Kavanagh.

Stay tuned for more. And let us know what you think in the comments.

To get notified when new videos are uploaded, follow our YouTube channel by clicking the red "subscribe" button.  [Tyee]

Read more: Health, Coronavirus

Share this article

The Tyee is supported by readers like you

Join us and grow independent media in Canada

Facts matter. Get The Tyee's in-depth journalism delivered to your inbox for free

Tyee Commenting Guidelines

Do not:

  •  Use sexist, classist, racist or homophobic language
  • Libel or defame
  • Bully, threaten, name-call or troll
  • Troll patrol. Instead, downvote, or flag suspect activity
  • Attempt to guess other commenters’ real-life identities

Do:

  • Verify facts, debunk rumours
  • Add context and background
  • Spot typos and logical fallacies
  • Highlight reporting blind spots
  • Ignore trolls and flag violations
  • Treat all with respect and curiosity
  • Stay on topic
  • Connect with each other

LATEST STORIES

The Barometer

Tyee Poll: Are You Preparing for the Next Climate Disaster?

Take this week's poll